Trial · NCT01709331
Adverse events18
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 18 of 18
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Abdominal pain | Gastrointestinal disorders | Corifollitropin Alfa 150 μg + hCG | 1 | 18 | 1 |
| other | Diarrhoea | Gastrointestinal disorders | Corifollitropin Alfa 150 μg + hCG | 1 | 18 | 1 |
| other | Haemorrhoids | Gastrointestinal disorders | Corifollitropin Alfa 150 μg + hCG | 1 | 18 | 1 |
| other | Seasonal allergy | Immune system disorders | Corifollitropin Alfa 150 μg + hCG | 1 | 18 | 1 |
| other | Conjunctivitis | Infections and infestations | Corifollitropin Alfa 150 μg + hCG | 1 | 18 | 1 |
| other | Nasopharyngitis | Infections and infestations | Corifollitropin Alfa 150 μg + hCG | 4 | 18 | 5 |
| other | Blood pressure increased | Investigations | Corifollitropin Alfa 150 μg + hCG | 1 | 18 | 1 |
| other | Blood testosterone increased | Investigations | Corifollitropin Alfa 150 μg + hCG | 2 | 18 | 2 |
| other | Oestradiol increased | Investigations | Corifollitropin Alfa 150 μg + hCG | 3 | 18 | 4 |
| other | Testicular scan abnormal | Investigations | Corifollitropin Alfa 150 μg + hCG | 1 | 18 | 1 |
| other | Musculoskeletal pain | Musculoskeletal and connective tissue disorders | Corifollitropin Alfa 150 μg + hCG | 1 | 18 | 1 |
| other | Headache | Nervous system disorders | Corifollitropin Alfa 150 μg + hCG | 3 | 18 | 4 |
| other | Breast tenderness | Reproductive system and breast disorders | Corifollitropin Alfa 150 μg + hCG | 1 | 18 | 1 |
| other | Acne | Skin and subcutaneous tissue disorders | Corifollitropin Alfa 150 μg + hCG | 1 | 18 | 1 |
| other | Alopecia | Skin and subcutaneous tissue disorders | Corifollitropin Alfa 150 μg + hCG | 1 | 18 | 1 |
| other | Hyperhidrosis | Skin and subcutaneous tissue disorders | Corifollitropin Alfa 150 μg + hCG | 1 | 18 | 1 |
| other | Flushing | Vascular disorders | Corifollitropin Alfa 150 μg + hCG | 1 | 18 | 1 |
| other | Blood testosterone decreased | Investigations | Corifollitropin Alfa 150 μg + hCG | 2 | 18 | 2 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01709331/events